Advancement in researches of treatment of primary gallbladder carcinoma by DCs vaccines
10.3760/cma.j.issn.1007-8118.2010.11.036
- VernacularTitle:DCs疫苗治疗原发性胆囊癌研究进展
- Author:
Jian GAO
;
Xingyuan JIAO
;
Jingsen SHI
- Publication Type:Journal Article
- Keywords:
Dendritic cells;
Gallbladder neoplasms;
Indoleamine 2,3-dioxygenase
- From:
Chinese Journal of Hepatobiliary Surgery
2010;16(11):892-895
- CountryChina
- Language:Chinese
-
Abstract:
Primary carcinoma of the gallbladder (PCG)is the common malignant tumor in the biliary system.Because there is no specific clinical manifestation, patients diagnosed with PCG are mostlyin intermediate or advanced stages.Therefore, they lose the chance of radical resection of gallbladder carcinoma and have a poor prognosis.Radiotherapy and chemotherapy are not effective palliative measures.Immunotherapy has become an alternative strategy besides operation, chemotherapy and radiotherapy.Treatment with DCs vaccines, as a new method of immunotherapy, has become more and more important.Here we review treatment with DCs vaccines in primary carcinoma of gallbladder.
